Novolog (Pharm-Up 1966) Ltd (TLV: NVLG)

Novolog (Pharm-Up 1966) Revenue

Novolog (Pharm-Up 1966) had revenue of 427.97M ILS in the quarter ending June 30, 2024, with 3.61% growth. This brings the company's revenue in the last twelve months to 1.68B, up 5.37% year-over-year. In the year 2023, Novolog (Pharm-Up 1966) had annual revenue of 1.64B with 8.99% growth.

• Revenue (ttm): 1.68B
• Revenue Growth: +5.37%
• P/S Ratio: 0.49
• Revenue / Employee: 1.76M
• Employees: 955
• Market Cap: 829.92M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.64B	135.54M	8.99%
Dec 31, 2022	1.51B	252.70M	20.13%
Dec 31, 2021	1.26B	121.61M	10.73%
Dec 31, 2020	1.13B	129.51M	12.90%
Dec 31, 2019	1.00B	94.17M	10.35%